[Health&Healing] Mandatory Vaccination Boost Corporate Profits

[Guest guest]

Comments?

Misty L. Trepke

http://www..com

 

Mandatory vaccination to boost corporate profits = eugenics

 

Mandatory vaccination of all Americans in order to boost corporate

profits and create the very flu-pandemic the vaccine is supposed to

prevent.... A eugenics program if there ever was one. See two news

articles below (CHRISTIAN SCIENCE MONITOR - Flu Vaccines for ALL and

REUTERS - Flu Vaccine Makers Say Gov't Must Increase Demand)

 

NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER

Vienna, Virginia http://www.nvic.org

 

* * * * * * * * * * * * * * * * * * * * * * *

UNITED WAY/COMBINED FEDERAL CAMPAIGN

#9119

* * * * * * * * * * * * * * * * * * * * * * *

 

" Protecting the health and informed consent rights of children since

1982. "

 

March 11, 2004

FROM THE CHRISTIAN SCIENCE MONITOR

http://www.csmonitor.com/2004/0311/p12s02-usgn.html

 

Flu vaccines for all?

As a federal advisory panel considers recommending universal

vaccination, some groups point out drawbacks.

By Gregory M. Lamb

 

An advisory group to the federal government is considering

recommending that all Americans receive annual flu vaccinations, a

step that would result in the largest vaccination effort in United

States history.

 

Although millions of Americans are vaccinated for a number of other

diseases, such as tetanus, diphtheria, and measles, those

inoculations require at most a new vaccination every 10 years. But a

flu- vaccine program would require yearly inoculations because of

constantly changing strains of the disease.

 

Advocates say the program would reduce incidence of the disease and,

quite possibly, reduce fatalities. It would also give drug

manufacturers a larger and predictable market for their vaccines, so

that shortages would not occur during major epidemics. But some

observers are balking. Many Americans have ethical, medical, or

religious objections to being vaccinated, they point out. Others

suffer from side effects of the vaccine.

 

" There are a couple of big implications here, " says Keiji Fukuda, an

epidemiologist at the Centers for Disease Control and Prevention

(CDC) in Atlanta. Right now, " there is no vaccine program which

targets everybody in the country to get annually vaccinated. The

logistics of something like this would be really immense. It would

simply be much larger than any other vaccination program in the

country. "

 

The discussion also represents an ongoing change in philosophy at the

Advisory Committee on Immunization Practices, the group that is

advising the CDC on vaccination policy. " It's a direction toward

which the ACIP has been moving in the past few years in terms of

broadening its recommendations for who should get vaccinated, " Dr.

Fukuda says in a phone interview. He presented the issue of

nationwide vaccination to the ACIP last month.

 

Not everyone is comfortable with the idea. Although the new

standards would remain recommendations, they would set in motion a

number of steps that would pressure all Americans to comply, says

Barbara Loe Fisher, president of the National Vaccination

Information Center. The Vienna, Va., group advocates a cautious

approach toward vaccinations. " I think the move is to universal use

by all citizens, " she says by phone. " And I think that's a very

questionable step. "

 

Are mandates inevitable?

When the CDC puts a universal-use label on a vaccine, " we know that

mandates will follow, " Ms. Fisher says. For example, it would be a

signal to states " to add it to the mandatory vaccination

requirements for children who want to go to school. " Employers might

require it. And the vaccines would probably be covered under the

National Childhood Vaccine Injury Act, which protects vaccine

manufacturers from liability suits from those who feel they've been

harmed.

 

In settings such as schools where vaccinations are required, only

about one-third of states offer exemptions based on philosophical or

personal beliefs. And " they are very hard to come by, " Fisher

says. " When doctors give them, many times state health officials

come in and second-guess the doctor and make the doctor's life

miserable. So very few doctors do give medical exemptions. "

 

Religious exemptions

All states but two offer religious exemptions, she says, but these

can also be difficult to obtain. " We have cases where parents who

have tried to exercise their religious exemption to vaccination have

been hauled into rooms with lawyers and grilled for four hours

about ... the sincerity of their religious beliefs. "

 

While Fisher represents a minority view, many others see universal

vaccination as desirable and inevitable. " I think it is something

that is going to happen, and I think it's something that is called

for, " says Len Novick, executive director of the National Foundation

for Infectious Diseases (NFID). The Bethesda, Md., coalition

represents private and public healthcare groups and industries,

including drug manufacturers.

 

The CDC currently recommends vaccinations for children between 6 and

23 months old, adults 50 and older, pregnant women, and others with

certain medical conditions. During this flu season, some 29 percent

of Americans were vaccinated. A recommendation for universal

coverage would probably include all Americans over 6 months of age.

 

Fukuda says the universal standard has at least two potential major

benefits. " It is possible, not proven, that you would increase the

protection of people who are at higher risk, " he says, such as the

elderly, by reducing the number of people around them carrying the

flu virus. And a more robust manufacturing and distribution system

for vaccines would be very useful when and if a major pandemic hits.

 

Last fall an early spike in reports of flu in the western US

resulted in alarming nationwide headlines predicting a severe flu

season. As the public rushed to get inoculated, spot shortages of

vaccine added to public fears. Healthcare professionals tried to

calm the concerns, the NFID's Mr. Novick says, by pointing out that

every flu seasons is different and that an early surge in reported

cases does not necessarily portend an especially severe year.

 

That appears to be true this year, as reported cases have dropped

dramatically and are now well below the average for this time of

year. CDC officials tentatively describe this year's flu season,

which is now winding down, as average or slightly worse than average.

 

An ACIP subgroup on influenza will continue to research the issue of

universal coverage and report back to the full committee, Fukuda

says. " I think the earliest it would go for a vote would be some

time in October 2005, " he says, with its earliest use as a standard

coming in 2006.

 

BL Fisher Note:

 

Three quarters of all Americans have historically just said NO

THANKS to getting a flu shot every year. But forced flu vaccination

of all Americans is just around the corner because vaccine

manufacturers don't want to lose any money on a product few people

buy and use. If the pharmaceutical industry gets what it wants from

Congress, watch for future flu vaccine mandates and societal

sanctions for children and adults who do not comply.

 

http://www.reuters.com/newsArticle.jhtml?

type=healthNews & storyID=43495

34

REUTERS

 

Flu Vaccine Makers Say Gov't Must Increase Demand

Thu Feb 12, 2004 05:56 PM ET

 

By Susan Heavey

WASHINGTON (Reuters) - Vaccine makers can not guarantee enough future

supplies of flu vaccines unless the government can help ensure

profitability, drug company officials told U.S. Congress on Thursday.

 

Unless the market is expanded -- either by ensuring that more at-

risk people get vaccinations for influenza or simply more people in

general, companies have little incentive for innovation, the

executives said.

 

" Raising demand is key to raising supply, " Howard Pien, president

and chief executive officer of Emeryville, Calif.-based Chiron Corp.

said.

 

The three companies that make flu vaccines for the U.S. market --

AventisSA, Chiron and MedImmune Inc. presented testimony at a

meeting of the U.S. House Government Reform Committee.

 

This year's flu season hit early and was heavily covered by the

media, creating vaccine shortages as people rushed to get flu shots.

 

The shortage also left many officials wondering what would happen if

a severe flu pandemic were to break out.

 

" The next flu pandemic could be right around the corner, " U.S. Rep.

Henry Waxman (D-Calif.) said at the meeting.

 

But manufacturers said they need steady demand when there isn't a

pandemic in order to have the capacity to quickly increase

production during an emergency -- otherwise they could loose money

on unused equipment and doses.

 

MedImmune, which makes the nasal spray flu vaccine called FluMist,

said current approved use for the spray -- individuals ages 5 to 49 -

- was too narrow.

 

The U.S. Centers for Disease Control and Prevention recommends the

vaccine for children between 6 and 23 months old and adults 65 and

older -- two groups it considers at higher risk for the disease.

 

" A universal recommendation... will in turn provide the impetus on

the part of vaccine manufacturers to increase their production

capacity to meet routine demand, " James Young, president of Research

and Development at MedImmune, said.

 

The Gaithersburg, Md.-based MedImmune also said the past year was

one of " lost opportunities " in which 4 million of 5 million FluMist

doses went unused.

 

" Our very public experience this season will most certainly have a

chilling effect on others who are considering entry into this

business, " Young said.

 

FluMist is co-marketed with Wyeth, which gets a share of the drug's

profits. The spray can also cost up to three times as much as a flu

shot.

 

Shares of MedImmune closed up 46 cents, or 1.8 percent, to $25.99 on

Nasdaq. Chiron shares fell 44 cents to close at $52.80 on Nasdaq,

and Wyeth shares closed down 14 cents on the New York Stock Exchange.

 

------------

And here you have the beginning...

http://www.reutershealth.com/archive/2004/03/11/eline/links/20040311e

lin005.html

 

New U.S. guidelines stress flu shots for babies.

 

Last Updated: 2004-03-11 12:24:17 -0400 (Reuters Health)

 

WASHINGTON (Reuters) - The American Academy of Pediatrics updated its

guidelines on Wednesday for influenza vaccines, saying healthy

babies under the age of 2 should be routinely immunized against the

virus...

 

-

Dawn Richardson

PROVE(Parents Requesting Open Vaccine Education)

prove@v... (email)

http://vaccineinfo.net/ (web site)

-

PROVE provides information on vaccines, and immunization policies and

practices that affect the children and adults of Texas. Our mission

is to prevent vaccine injury and death and to promote and protect

the right of every person to make informed independent vaccination

decisions for themselves and their family.

-----